Developing a Point-of-Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings SBIR (R43/ R44)

The summary for the Developing a Point-of-Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings SBIR (R43/ R44) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Developing a Point-of-Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings SBIR (R43/ R44): This FOA encourages applications that propose to develop a point of care (POC) device for the diagnosis of sickle cell disease (SCD) in infants and young children in low-income and low-resource settings. The aim of this program is to provide rapid diagnosis of SCD to children such that appropriate therapy can be given to reduce the risk of future complications.
Federal Grant Title: Developing a Point-of-Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings SBIR (R43/ R44)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-14-010
Type of Funding: Grant
CFDA Numbers: 93.839
CFDA Descriptions: Blood Diseases and Resources Research
Current Application Deadline: Oct 23, 2015
Original Application Deadline: Oct 23, 2015
Posted Date: Jul 08, 2013
Creation Date: Jul 08, 2013
Archive Date: Nov 23, 2015
Total Program Funding:
Maximum Federal Grant Award: $225,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immu...
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (...
Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional)
Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional)
Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
Clinical Hematology Research Career Development Program (K12)
Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com